Key facts
- Function Health’s last known valuation is $2.5B (Nov 2025).
- It has raised $357.6M; the latest was Early Stage VC ($300.0M) in Nov 2025.
- Notable investors include Alumni Ventures, Andreessen Horowitz, K5 Global, Battery Ventures, Jeff Dean — 51 tracked in total.
- Status: Privately Held (backing).
Leadership
- Daniel SwerdlinFounder & General Counsel
- Danna ChungChief Medical Officer
- Jonathan SwerdlinChief Executive Officer & Founder
- Neil ShahChief Operating Officer
- ·The complete investor list — 51 names
- ·Watchlist + deal alerts for Function Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Function Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Function Health
Developer of a health empowerment platform designed to empower individuals to pursue a lifetime of avoiding disease and feeling their healthy. The company offers routine whole-body lab testing, advanced imaging, and personalized insights from leading medical experts, enabling individuals focused on proactive health to own their health journey with predictive and protective data.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2022
- Employees
- 29
- Website
- functionhealth.com/
- Ownership
- Privately Held (backing)
Function Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Function Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Function Health in its N-PORT filings yet. We sweep new filings monthly.